Please wait...
About This Project
An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan parasite Trypanosoma cruzi that results in Chagas’ disease, a neglected tropical disease (NTD). Principally spread by the kissing bug (cover image), there exists an urgent need for development of new therapeutics to replace the outdated clinically used drugs, benznidazole and nifurtimox. Our research focuses on the discovery of novel antichagasic compounds for improved medicine.
Browse Other Projects on Experiment
Related Projects
Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection
We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...
How does taking Ritalin affect depersonalization-derealization disorder patients?
We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...
Developing a modular paper-based detection device for Tuberculosis
The Michigan Synthetic Biology Team is developing a novel diagnostic device that will enable the detection...